Viral states and immune competence in Epstein–Barr virus-positive diffuse large B-cell lymphoma: conditions for therapeutic targeting
Epstein–Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) exhibits distinct viral expression, antigen-presentation and immune states that shape therapeutic opportunities. Malignant-cell viral attribution anchors diagnosis, while therapeutic activity depends on the target and mechanism being engaged. This...